Skip to main content
. Author manuscript; available in PMC: 2021 Apr 2.
Published in final edited form as: Am J Prev Med. 2020 Dec 5;60(4):546–551. doi: 10.1016/j.amepre.2020.10.011

Appendix Table 1.

Cohort Flow Descriptions

Step Description Number of patients Number of person-years
Prevalence cohort
1  All opioid users 12,930,228
2  At least 90 days opioid use (opioid use periods)a 1,298,048 2,570,004
3  Continuous eligibility for entire calendar year and previous yeara 727,693 1,580,955
4  At least 18 years old at time of first opioid use, had known gender, region 721,843 1,570,054
5  Had no acute pain conditions for entire calendar year 621,449 1,228,044
Incidence cohort
1  All opioid users 12,930,228
2  At least 90 days opioid use (opioid use periods)a 1,298,048 2,570,004
3  Continuous eligibility for 1 year prior to start of long-term opioid use 665,377 1,311,672
4  No prior opioid use in 1 year prior to start of long-term opioid use 49,893 50,426
5  At least 18 years old at time of first opioid use, had known gender, region 49,508 50,040
6  First opioid prescription for at least 28 days 35,682 36,194
7  Had no acute pain conditions in prior to first opioid use 28,790 29,202
a

LTOT users could be counted for multiple years if they had at least 90 days of opioid use in each calendar year. For users with only 1 episode of ≥90 days use which spanned across 2 calendar years, the earlier year was used as the year of use, if it included at least 30 days of use. Otherwise, the later year was selected. For example, an LTOT user with 90 days’ use starting December 1, 2012 and ending February 28, 2013 would count for 2012 because the episode had 31 days’ use in 2012. An LTOT user with 90 days use starting December 3, 2012 and ending March 2 would count for 2013 because the episode included only 29 days of use in 2012.

LTOT, long term opioid therapy.